These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8096798)

  • 21. Amplification of protooncogenes in surgical specimens of human lung carcinomas.
    Shiraishi M; Noguchi M; Shimosato Y; Sekiya T
    Cancer Res; 1989 Dec; 49(23):6474-9. PubMed ID: 2573414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. c-myc amplification is associated with HER2 amplification and closely linked with cell proliferation in tissue microarray of nonselected breast cancers.
    Park K; Kwak K; Kim J; Lim S; Han S
    Hum Pathol; 2005 Jun; 36(6):634-9. PubMed ID: 16021569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of Her2/neu, c-MYC and ZNF217 gene amplification during breast cancer progression using fluorescence in situ hybridization.
    Shimada M; Imura J; Kozaki T; Fujimori T; Asakawa S; Shimizu N; Kawaguchi R
    Oncol Rep; 2005 Apr; 13(4):633-41. PubMed ID: 15756435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG; Ethier SP
    Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of c-myc amplification and overexpression in breast cancer patients: evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathological characteristics using univariate and multivariate analysis.
    Scorilas A; Trangas T; Yotis J; Pateras C; Talieri M
    Br J Cancer; 1999 Dec; 81(8):1385-91. PubMed ID: 10604737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proto-oncogene abnormalities in human breast cancer: c-ERBB-2 amplification does not correlate with recurrence of disease.
    Zhou DJ; Ahuja H; Cline MJ
    Oncogene; 1989 Jan; 4(1):105-8. PubMed ID: 2915899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Correlation between DNA content and amplification of oncogenes (c-myc, L-myc, c-erbB-2) and correlation with prognosis in 143 cases of resected lung cancer].
    Chiba W; Sawai S; Hanawa T; Ishida H; Matsui T; Kosaba S; Watanabe S; Hatakenaka R; Matsubara Y; Funatsu T
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):824-7. PubMed ID: 8098200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers: a role for hematopoietic growth factor release by tumor cells?
    Tang RP; Kacinski B; Validire P; Beuvon F; Sastre X; Benoit P; dela Rochefordière A; Mosseri V; Pouillart P; Scholl S
    J Cell Biochem; 1990 Nov; 44(3):189-98. PubMed ID: 1980125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-level expression of the ribosomal protein L19 in human breast tumors that overexpress erbB-2.
    Henry JL; Coggin DL; King CR
    Cancer Res; 1993 Mar; 53(6):1403-8. PubMed ID: 8095182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene.
    Singleton TP; Strickler JG
    Pathol Annu; 1992; 27 Pt 1():165-90. PubMed ID: 1346551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
    Yang KP; Castillo SG; Nguyen CV; Hickey RC; Samaan NA
    Anticancer Res; 1990; 10(1):189-92. PubMed ID: 2185686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Amplification of oncogenes HER2, mdm-2 and myc in breast cancer determined by modified competitive PCR].
    Deng GR; He LW; Lu YY
    Zhonghua Yi Xue Za Zhi; 1995 Feb; 75(2):100-3, 127. PubMed ID: 7767763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment of the human BSMZ breast cancer cell line, which overexpresses the erbB-2 and c-myc genes.
    Watanabe M; Tanaka H; Kamada M; Okano JH; Takahashi H; Uchida K; Iwamura A; Zeniya M; Ohno T
    Cancer Res; 1992 Oct; 52(19):5178-82. PubMed ID: 1356615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers.
    Grushko TA; Blackwood MA; Schumm PL; Hagos FG; Adeyanju MO; Feldman MD; Sanders MO; Weber BL; Olopade OI
    Cancer Res; 2002 Mar; 62(5):1481-8. PubMed ID: 11888924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH.
    Wang ZR; Liu W; Smith ST; Parrish RS; Young SR
    Exp Mol Pathol; 1999 Jun; 66(2):140-8. PubMed ID: 10409442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line.
    Ethier SP; Kokeny KE; Ridings JW; Dilts CA
    Cancer Res; 1996 Feb; 56(4):899-907. PubMed ID: 8631031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative detection of amplification of proto-oncogenes in breast cancer.
    Chen Y; Dong J; Lu Y; McGee JO
    Chin Med J (Engl); 1995 Nov; 108(11):849-54. PubMed ID: 8585979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative polymerase chain reaction analysis of c-myc amplification on archival breast fine-needle aspiration materials.
    Rao JY; Apple SK; Jin Y; Lin S; Nieberg RK; Hirtschowitz SL
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):175-9. PubMed ID: 10698478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
    Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
    Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal FHIT gene transcript and c-myc and c-erbB2 amplification in breast cancer.
    Kowara R; Gołebiowski F; Chrzan P; Skokowski J; Karmolinski A; Pawełczyk T
    Acta Biochim Pol; 2002; 49(2):341-50. PubMed ID: 12362975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.